Related Experiment Video
Updated: Jan 13, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity
Jagoda Siemaszko1, Katarzyna Grad1, Jerzy Świerkot2
1Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Background:
The emergence of the COVID-19 pandemic has accelerated research into diverse immune response mechanisms. One key area of interest is the regulation of cytotoxic activity by Natural Killer (NK) cells. These cells rely on a dynamic interplay between activating and inhibitory surface receptors that recognize specific ligands on target cells. Among these, receptors from the NKG2 family are particularly important, as maintaining their proper balance and function is essential for controlling NK cell cytotoxicity.
Methods:
In this study we employed qPCR to assess the genetic variability using single-nucleotide polymorphisms (SNPs) of NKG2A and NKG2D receptors and their ligands HLA-E and MICA/MICB. NKG2C deletion was determined by PCR-SSP, and serum-soluble levels of HLA-E and MICA/MICB molecules were measured by ELISA and Luminex methods.
Results:
Genotyping studies revealed that both NKG2A rs7301582 T and HLA-E rs1264457 A (HLA-E*01:01) alleles were predominant among infected individuals (OR = 2.21, p = 0.0258 and OR = 2.84, p = 0.0257, respectively). In contrast to MICB rs1065075 A, the MICA rs1051792 A (129Met) allele was most commonly found in hospitalized patients (OR = 14.95, p = 0.0114). The presence of the NKG2C del variant tended to be associated with an increased risk of SARS-CoV-2 infection (OR = 2.02, p = 0.0694). Moreover, higher concentrations of serum-soluble MICB was detected in infected individuals as compared to the control group (p = 0.008).
Conclusions:
Genetic variability of NK cell receptors and ligands as well as serum levels of their soluble forms showed associations with the risk of development of COVID-19 and the severity of its symptoms.
Insights
Genetic variations in Natural Killer (NK) cell receptors and their ligands are linked to COVID-19 risk and symptom severity. Specific alleles and soluble protein levels influence disease outcomes in SARS-CoV-2 infection.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- COVID-19 pandemic spurred research into immune responses.
- Natural Killer (NK) cell cytotoxic activity is regulated by activating and inhibitory receptors.
- NKG2 family receptors are crucial for NK cell function and cytotoxicity control.
Purpose of the Study:
- To investigate the genetic variability of NKG2A, NKG2D, HLA-E, MICA/MICB, and NKG2C deletion.
- To assess the association between genetic polymorphisms and serum-soluble levels of these molecules with COVID-19 risk and severity.
Main Methods:
- Quantitative PCR (qPCR) for single-nucleotide polymorphisms (SNPs) in NKG2A, NKG2D, MICA/MICB.
- PCR-SSP for NKG2C deletion.
- ELISA and Luminex assays for serum-soluble HLA-E and MICA/MICB levels.
Main Results:
- Predominant NKG2A and HLA-E alleles found in infected individuals.
- MICA allele (129Met) common in hospitalized patients.
- NKG2C deletion associated with increased SARS-CoV-2 infection risk.
- Elevated serum-soluble MICB levels in infected individuals.
Conclusions:
- Genetic variability in NK cell receptors and ligands correlates with COVID-19 susceptibility.
- Serum levels of soluble NK cell receptor ligands are associated with COVID-19 severity.
- These findings highlight the role of NK cell-mediated immunity in SARS-CoV-2 infection.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Leaky Scanning
Mutation, Gene Flow, and Genetic Drift

